E
Eli Lilly and Company (LLY)
NYQ – Real vaqt narxi. Valyuta: USD
989.87
+22.88 (2.37%)
Yopilishda: May 12, 2026, 4:00 PM EDT
984.14
-5.67 (-0.57%)
Bozor oldidan: May 13, 2026, 5:39 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
989.87
+22.88 (2.37%)
Yopilishda: May 12, 2026, 4:00 PM EDT
984.14
-5.67 (-0.57%)
Bozor oldidan: May 13, 2026, 5:39 AM EDT
Eli Lilly and Company Qo'shma Shtatlar, Evropa, Xitoy, Yaponiya va xalqaro miqyosda inson farmatsevtika mahsulotlarini kashf qiladi, ishlab chiqadi, ishlab chiqaradi va sotadi. Kompaniya diabet uchun Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, Humulin U-500 kabi kardiyometabolik sog'liq mahsulotlarini taklif etadi; 2-toifa diabet uchun Jardiance, Mounjaro va Trulicity; va semirish uchun Zepbound. Shuningdek, u oshqozon saratoni yoki oshqozon-qizilo'ngach birlashmasi adenokarsinomasini ikkinchi bosqichda davolash uchun Cyramza; kolorektal saraton va bosh va bo'yin saratonlari uchun Erbitux; ko'krak bezi saratoni uchun Inluriyo; surunkali limfotsitar leykemiya yoki kichik limfotsitar limfoma uchun Jaypirca; metastatik NSCLCni davolash uchun Retevmo; klassik Xodjkin limfomasi uchun TYVYT; va ko'krak bezi saratoni uchun Verzenio kabi onkologiya mahsulotlarini taqdim etadi. Bundan tashqari, kompaniya immunitet mahsulotlarini taklif etadi, jumladan, og'ir atopik dermatit uchun Ebglyss; revmatoid artrit, atopik dermatit, og'ir soch to'kilishi va COVID-19 uchun Olumiant; yarali kolit uchun Omvoh; va blyashka psoriaz, psoriatik artrit, ankilozlovchi spondilit va rentgenologik bo'lmagan o'q spondiloartrit uchun Taltz. Shuningdek, u migrenni oldini olish va paroksizmal klaster bosh og'rig'i uchun Emgality, shuningdek, simptomatik Altsgeymer kasalligi uchun Kisubla taqdim etadi. Kompaniya Jardiance mahsulot oilasi uchun Boehringer Ingelheim Pharmaceuticals, Inc. bilan; va lebrikizumab uchun F. Hoffmann-La Roche Ltd va Genentech, Inc. bilan hamkorlikni yo'lga qo'ygan, shuningdek, Ebglyss uchun Almirall, S.A. bilan; va orforglipron uchun Chugai Pharmaceutical Co., Ltd bilan litsenzion kelishuvlarga ega. Eli Lilly and Company 1876 yilda tashkil etilgan va shtab-kvartirasi Indiana shtatining Indianapolis shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Daniel M. Skovronsky M.D., Ph.D. | Chief Scientific & Product Officer and President of Lilly Research Laboratories |
| Mr. David A. Ricks | Chairman & CEO |
| Mr. Diogo Rau | Executive VP and Chief Information & Digital Officer |
| Mr. Donald A. Zakrowski | Senior VP of Finance & Chief Accounting Officer |
| Mr. Eric Dozier | Executive VP & Chief People Officer |
| Mr. Ilya Yuffa | Executive VP and President of Lilly USA & Global Customer Capabilities |
| Mr. Jacob S. Van Naarden | Executive VP, President of Lilly Oncology & Head of Corporate Business Development |
| Mr. Lucas E. Montarce | Executive VP & CFO |
| Mr. Michael Czapar | Director of Investor Relations |
| Ms. Anat Hakim J.D. | Executive VP, General Counsel & Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-11 | SD | formsd2026.htm |
| 2026-05-07 | 8-K | lly-20260504.htm |
| 2026-04-30 | 10-Q | lly-20260331.htm |
| 2026-03-31 | DFAN14A | d111268ddfan14a.htm |
| 2026-03-20 | DEF 14A | lly-20260317.htm |
| 2026-03-06 | PRE 14A | lly-20260306.htm |
| 2026-02-12 | 10-K | lly-20251231.htm |
| 2026-02-04 | 8-K | lly-20260204.htm |
| 2025-12-09 | SC TO-T/A | d14417dsctota.htm |
| 2025-11-21 | 8-K | lly-20251118.htm |